Gyre Therapeutics (GYRE) Gross Profit (2020 - 2025)
Historic Gross Profit for Gyre Therapeutics (GYRE) over the last 7 years, with Q3 2025 value amounting to $28.9 million.
- Gyre Therapeutics' Gross Profit rose 1796.17% to $28.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $102.4 million, marking a year-over-year increase of 132.47%. This contributed to the annual value of $101.9 million for FY2024, which is 637.88% down from last year.
- According to the latest figures from Q3 2025, Gyre Therapeutics' Gross Profit is $28.9 million, which was up 1796.17% from $25.6 million recorded in Q2 2025.
- Gyre Therapeutics' Gross Profit's 5-year high stood at $48.1 million during Q4 2022, with a 5-year trough of -$14000.0 in Q4 2021.
- Its 5-year average for Gross Profit is $19.7 million, with a median of $24.5 million in 2024.
- Per our database at Business Quant, Gyre Therapeutics' Gross Profit tumbled by 15714.29% in 2021 and then skyrocketed by 59525000.0% in 2023.
- Quarter analysis of 5 years shows Gyre Therapeutics' Gross Profit stood at -$14000.0 in 2021, then skyrocketed by 343357.14% to $48.1 million in 2022, then plummeted by 46.11% to $25.9 million in 2023, then rose by 3.08% to $26.7 million in 2024, then grew by 8.39% to $28.9 million in 2025.
- Its last three reported values are $28.9 million in Q3 2025, $25.6 million for Q2 2025, and $21.2 million during Q1 2025.